Boehringer Sues Amneal To Block Generic Aggrenox
Boehringer Ingelheim Pharmaceuticals Inc. hit Amneal Pharmaceuticals LLC with a lawsuit Wednesday in New Jersey federal court, claiming Amneal's plan to develop a generic version of Aggrenox, a long-acting aspirin, infringes...To view the full article, register now.
Already a subscriber? Click here to view full article